Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg.
⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose when taking this drug is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose).
⦁ Patients switching to this drug from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin.
When this drug is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions).
This drug should be taken with meals to reduce gastrointestinal adverse effects associated with metformin.
If you miss a dose of this drug, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose.
Special Populations
Patients with Renal Impairment
No dose adjustment is necessary in patients with mild renal impairment.
Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily.
Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)).
If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this drug should be discontinued immediately (see Precautions for Use, 2. Patients in Whom the Drug Is Contraindicated, item 2)).
Elderly Patients
In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
Improvement of glycemic control in adults with type 2 diabetes mellitus
Abnormal blood glucose control
type 2 diabetes
cardiovascular disease
cardiovascular events
View approved original textHide original text
This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is particularly suitable for patients whose blood sugar is not adequately controlled, and caution should be taken under the guidance of a healthcare professional in patients with cardiovascular disease. This medication helps improve blood glucose control and manage the risk of cardiovascular diseases.
How to take
Adult dose
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg.
⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose when taking this drug is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose).
⦁ Patients switching to this drug from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin.
When this drug is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions).
This drug should be taken with meals to reduce gastrointestinal adverse effects associated with metformin.
If you miss a dose of this drug, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose.
Special Populations
Patients with Renal Impairment
No dose adjustment is necessary in patients with mild renal impairment.
Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily.
Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)).
If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this drug should be discontinued immediately (see Precautions for Use, 2. Patients in Whom the Drug Is Contraindicated, item 2)).
Elderly Patients
In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
Precautions
This medication is used for the treatment of diabetes and helps lower blood sugar levels. However, there is a risk of rare but severe side effects such as lactic acidosis. Caution should be exercised when used with other diabetes medications, as there may be an increased risk of hypoglycemia. This medication should not be used in certain patients with severe renal impairment, acute renal problems, severe infections, heart failure, and others. Additionally, it should be temporarily discontinued before and after undergoing surgery or tests using iodinated contrast media. It is also advisable for pregnant or nursing women to avoid this medication. This medication may be affected by kidney function, and regular kidney function tests are recommended. Extra caution is needed if there is a risk of fluid loss or symptoms of dehydration. While taking this medication, patients should be aware of symptoms of hypoglycemia, and dosage adjustments may be necessary if using insulin or other hypoglycemic agents. Urinary tract or genital infections may occur during treatment; if symptoms appear, consult healthcare providers immediately. Vitamin B12 deficiency may occur; therefore, routine blood tests during long-term treatment are recommended. Alcohol consumption may increase the risk of lactic acidosis, so it is safer to avoid it. If abnormal symptoms occur while taking this medication, consult a doctor immediately. This medication is not recommended for children or teenagers under the age of 18. Elderly patients should have their dosage adjusted and monitored carefully due to the risk of reduced kidney function. In case of overdose, seek immediate medical attention; blood dialysis may be required. This medication should be stored out of reach of children and kept in its original container.
Side effects
Hypoglycemia
urinary tract infection
genital infection
increased urination
nausea
vomiting
diarrhea
abdominal pain
loss of appetite
constipation
Show 177 moreCollapse
abnormal liver function tests
hepatitis
taste alteration
itching
rash
urticaria
erythema
angioedema
dysuria
interstitial nephritis
thirst
increased serum lipids
elevated serum creatinine
decreased glomerular filtration rate
vaginitis
vulvovaginitis
balanitis
perineal necrosis
decreased fluid volume
vitamin B12 deficiency and reduction
ketoacidosis
lactic acidosis
headache
dizziness
cerebral infarction
soft tissue infection
pneumonia
ankle fracture
epicondylitis
facial bone fracture
musculoskeletal pain
myocardial infarction
diarrhea
nausea
gastric ulcer
colitis
ischemic colitis
gastrointestinal bleeding
appendiceal abscess
appendicitis
meningitis
chronic otitis media
peritonsillar abscess
pulmonary tuberculosis
acute pyelonephritis
sepsis
subcutaneous abscess
adnexal-ovarian abscess
vestibular neuritis
headache
positional dizziness
sensory loss
amnesia
facial paralysis
drowsiness
CNS origin vertigo
fatigue
peripheral edema
facial edema
fever
chills
strange sensations
edema
pain
pain at the puncture site
vascular stent stenosis
vascular stent thrombosis
chest pain
weight loss
vulvar pruritus
benign prostatic hyperplasia
diabetic retinopathy
double vision
hypertension
insomnia
epistaxis
asthma
exertional dyspnea
productive cough
allergic rhinitis
residual phlegm
skin laceration
contusion
rib fracture
concussion
corneal abrasion
falls
hand fracture
iliotibial band syndrome
open globe injury
pelvic fracture
road traffic accidents
splenic injury
sternal fracture
angina
palpitations
Prinzmetal angina
coronary artery disease
tachycardia
atherosclerosis
deep vein thrombosis
diabetic vascular complications
peripheral arterial occlusive disease
anxiety
depression
sleep disorders
otalgia
positional vertigo
vertigo
anemia
lymphadenopathy
hypothyroidism
thyroid nodule
constipation
dyspepsia
gastritis
gastrointestinal disorder
herpes zoster
cervicitis
hyperglycemia
hyponatremia
dermal cyst
seborrheic dermatitis
atopic dermatitis
diabetic foot
nummular eczema
heat rash
sebaceous gland hyperplasia
lumbar spinal stenosis
myalgia
limb pain
musculoskeletal chest pain
arthralgia
cervical stenosis
fibromyalgia
flank pain
fracture pain
muscle weakness
osteoarthritis
osteoporosis
rotator cuff syndrome
astigmatism
cataract
allergic conjunctivitis
blurred vision
corneal erosion
macular fibrosis
ocular discomfort
conjunctival injection
pathological myopia
retinal detachment
retinal deposits
retinal vein occlusion
traction retinal detachment
eyelid swelling
visual impairment
vitreous floaters
vitreous hemorrhage
epistaxis
asthma
exertional dyspnea
productive cough
allergic rhinitis
residual phlegm
skin laceration
rib fracture
iliotibial band syndrome
unstable angina
angina
Prinzmetal angina
coronary artery disease
tachycardia
atherosclerosis
deep vein thrombosis
diabetic vascular complications
peripheral arterial occlusive disease
anxiety
Not everyone experiences these, and they can vary from person to person.
Storage
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature to maintain its effectiveness.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.